<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2022-16-21-78-87</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-7207</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГОЛОВНАЯ БОЛЬ И ГОЛОВОКРУЖЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>HEADACHE AND VERTIGO</subject></subj-group></article-categories><title-group><article-title>Клинико-психологические характеристики пациентов с мигренью</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and psychological characteristics of migraine patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2752-4109</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Головачева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovacheva</surname><given-names>V. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Головачева Вероника Александровна, к.м.н., доцент кафедры нервных болезней и нейрохирургии </p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Veronika A. Golovacheva, Cand. Sci. (Med.), Associate Professor of the Department of Nervous Diseases and Neurosurgery </p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">xoxo.veronicka@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2845-7323</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Головачева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovacheva</surname><given-names>А. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Головачева Анжелика Александровна, клинический ординатор кафедры нервных болезней и нейрохирургии </p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Anzhelika А. Golovacheva, Clinical Resident of the Department of Nervous Diseases and Neurosurgery </p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991</p></bio><email xlink:type="simple">angelika.golovacheva@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9879-0036</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Володарская</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Volodarskaya</surname><given-names>Е. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Володарская Елена Александровна, д.п.н., доцент, ведущий научный сотрудник отдела науковедения </p><p>125315, Москва, ул. Балтийская, д. 14</p></bio><bio xml:lang="en"><p>Elena А. Volodarskaya, Dr. Sci. (Ped.), Associate Professor, Lead Researcher of the Department of Scientific Studies </p><p>14, Baltiyskaya St., Moscow, 125315</p></bio><email xlink:type="simple">eavolod@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9282-3319</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бахтадзе</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakhtadze</surname><given-names>М. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бахтадзе Максим Альбертович, к.м.н., ведущий научный сотрудник лаборатории фундаментальных и прикладных проблем боли; ассистент кафедры неврологии, нейрохирургии и медицинской генетики лечебного факультета; врач-невролог, врач мануальной терапии</p><p>125315, Москва, ул. Балтийская, д. 8</p><p>117997, Москва, ул. Островитянова, д. 1</p><p>109004, Москва, Большой Дровяной переулок, д. 14, стр. 3</p></bio><bio xml:lang="en"><p>Maxim А. Bakhtadze, Cand. Sci. (Med.), Leading Researcher of the Laboratory of Fundamental and Applied Problems of Pain; Assistant of the Department of Neurology, Neurosurgery and Medical Genetics; Neurologist, Manual Therapist</p><p>8, Baltiyskaya St., Moscow, 125315</p><p>1, Ostrovityanov St., Moscow, 117997</p><p>14, Bldg. 3, Bolshoi Drovyanoy Lane, Moscow, 109004</p></bio><email xlink:type="simple">bmaksb@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт истории естествознания и техники имени С.И. Вавилова РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of the History of Natural History and Technology named after S.I. Vavilov, RAS</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт общей патологии и патофизиологии; Российский национальный исследовательский медицинский университет имени Н.И. Пирогова; Клиника восстановительной медицины «Качество жизни»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of General Pathology and Pathophysiology; Pirogov Russian National Research Medical University; Restorative Medicine Clinic “Quality of Life”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2022</year></pub-date><volume>0</volume><issue>21</issue><fpage>78</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Головачева В.А., Головачева А.А., Володарская Е.А., Бахтадзе М.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Головачева В.А., Головачева А.А., Володарская Е.А., Бахтадзе М.А.</copyright-holder><copyright-holder xml:lang="en">Golovacheva V.А., Golovacheva А.А., Volodarskaya Е.А., Bakhtadze М.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7207">https://www.med-sovet.pro/jour/article/view/7207</self-uri><abstract><p>Введение. Понимание клинико-психологических характеристик пациентов с мигренью необходимо для разработки эффективного междисциплинарного лечения, включающего психологические методы. Личностные особенности пациентов с мигренью продолжают изучаться и обсуждаться. Актуально исследование индивидуально-психологических характеристик личности у пациентов с мигренью различной частоты.Цель. Оценить клинико-психологические характеристики у пациентов с различной частотой мигрени.Материалы и методы. В исследование включено 60 пациентов с мигренью, средний возраст 32,92 ± 6,23 года. В зависимости от частоты мигрени все участники исследования распределялись в 1 из 3 групп: 1-я группа – пациенты с редкой эпизодической мигренью; 2-я группа – пациенты с частой эпизодической мигренью; 3-я группа – пациенты с хронической мигренью. Со всеми пациентами проводилась беседа и тестирование.Результаты и обсуждение. Достоверных различий между группами по средним показателям нейротизма, психотизма, экстраверсии, интроверсии не получено. В каждой группе у большинства пациентов была средняя выраженность нейротизма, а у всех остальных – ярко выраженный нейротизм; большинство пациентов были амбивалентны, т. е. имели черты и интроверта, и экстраверта, а остальные пациенты были чистыми экстравертами или чистыми интровертами. Ни у кого из пациентов не было ярко выраженного психотизма (склонности к неадекватным эмоциональным реакциям). В каждой группе преобладали пациенты с нормальным типом темперамента и темпераментами меланхолического спектра.Заключение. При хронической и частой эпизодической мигрени чаще встречаются депрессивные и тревожные расстройства, чем при редкой эпизодической мигрени. Нейротизм, психотизм, экстраверсия/интроверсия встречаются вне зависимости от частоты приступов мигрени.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Understanding the clinical and psychological characteristics of migraine patients is essential for developing effective multidisciplinary treatment that includes psychological methods. The personality characteristics of migraine patients continue to be studied and discussed. The study of individual-psychological characteristics of personality in patients with migraine of different frequency is topical.Aim. To assess clinical and psychological characteristics in patients with varying frequency of migraine.Materials and Methods. Sixty migraine patients, mean age 32.92 ± 6.23 years, were included in the study. Depending on the frequency of migraine, all study participants were allocated to 1 of 3 groups: Group 1 – patients with rare episodic migraine; Group 2 – patients with frequent episodic migraine; Group 3 – patients with chronic migraine. All patients were interviewed and tested.Results and discussion. There were no significant differences between the groups in terms of the mean values of neuroticism, psychoticism, extraversion or introversion. Most patients in each group were moderately neurotic and all others were highly neurotic; most patients were ambivalent, i.e., shared both introvert and extrovert personality traits, with the rest being either pure extrovert or pure introvert. None of the patients were psychotic (prone to inappropriate emotional reactions). In each group, patients with a normal temperament type and melancholic spectrum temperaments predominated.Conclusion. Depressive and anxiety disorders are more common in chronic and frequent episodic migraine than in rare episodic migraine. Neuroticism, psychoticism and extraversion/introversion were found regardless of the frequency of migraine attacks.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>качество жизни</kwd><kwd>тревога</kwd><kwd>депрессия</kwd><kwd>нейротизм</kwd><kwd>темперамент</kwd><kwd>экстраверсия</kwd><kwd>интроверсия</kwd><kwd>психологические особенности</kwd><kwd>личностные характеристики</kwd></kwd-group><kwd-group xml:lang="en"><kwd>quality of life</kwd><kwd>anxiety</kwd><kwd>depression</kwd><kwd>neuroticism</kwd><kwd>temperament</kwd><kwd>extraversion</kwd><kwd>introversion</kwd><kwd>psychological characteristics</kwd><kwd>personality traits</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Филатова Е.Г., Осипова В.В., Табеева Г.Р., Парфенов В.А., Екушева Е.В., Азимова Ю.Э. и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4–14. https://doi.org/10.14412/2074-2711-2020-4-4-14. Filatova E.G., Osipova V.V., Tabeeva G.R., Parfenov V.A., Ekusheva E.V., Azimova Yu.E. et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.</mixed-citation><mixed-citation xml:lang="en">Филатова Е.Г., Осипова В.В., Табеева Г.Р., Парфенов В.А., Екушева Е.В., Азимова Ю.Э. и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4–14. https://doi.org/10.14412/2074-2711-2020-4-4-14. Filatova E.G., Osipova V.V., Tabeeva G.R., Parfenov V.A., Ekusheva E.V., Azimova Yu.E. et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ayzenberg I., Katsarava Z., Sborowski A., Chernysh M., Osipova V., Tabeeva G. et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373–381. https://doi.org/10.1177/0333102412438977.</mixed-citation><mixed-citation xml:lang="en">Ayzenberg I., Katsarava Z., Sborowski A., Chernysh M., Osipova V., Tabeeva G. et al. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373–381. https://doi.org/10.1177/0333102412438977.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sacco S., Lampl C., Maassen van den Brink A., Caponnetto V., Braschinsky M., Ducros A. et al. Burden and Attitude to Resistant and Refractory (BARR) Study Group. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine &amp; Headache Alliance. J Headache Pain. 2021;22(1):39. https://doi.org/10.1186/s10194-021-01252-4.</mixed-citation><mixed-citation xml:lang="en">Sacco S., Lampl C., Maassen van den Brink A., Caponnetto V., Braschinsky M., Ducros A. et al. Burden and Attitude to Resistant and Refractory (BARR) Study Group. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine &amp; Headache Alliance. J Headache Pain. 2021;22(1):39. https://doi.org/10.1186/s10194-021-01252-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Safiri S., Pourfathi H., Eagan A., Mansournia M.A., Khodayari M.T., Sullman M.J.M. et al. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022;163(2):e293–e309. https://doi.org/10.1097/j.pain.0000000000002275.</mixed-citation><mixed-citation xml:lang="en">Safiri S., Pourfathi H., Eagan A., Mansournia M.A., Khodayari M.T., Sullman M.J.M. et al. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022;163(2):e293–e309. https://doi.org/10.1097/j.pain.0000000000002275.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Agostoni E.C., Barbanti P., Calabresi P., Colombo B., Cortelli P., Frediani F. et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019;20(1):92. https://doi.org/10.1186/s10194-019-1038-4.</mixed-citation><mixed-citation xml:lang="en">Agostoni E.C., Barbanti P., Calabresi P., Colombo B., Cortelli P., Frediani F. et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019;20(1):92. https://doi.org/10.1186/s10194-019-1038-4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–182. https://doi.org/10.1016/S1474-4422(17)30435-0.</mixed-citation><mixed-citation xml:lang="en">Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–182. https://doi.org/10.1016/S1474-4422(17)30435-0.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Головачева В.А., Головачева А.А., Парфенов В.А. Терапия при хронической мигрени: междисциплинарный подход. Клиническое наблюдение. Терапевтический архив. 2021;93(12):1528–1532. https://doi.org/10.26442/00403660.2021.12.201247. Golovacheva V.A., Golovacheva A.A., Parfenov V.A. Chronic migraine treatment: multidisciplinary approach. Case report. Terapevticheskii Arkhiv. 2021;93(12): 1528–1532. (In Russ.) https://doi.org/10.26442/00403660.2021.12.201247.</mixed-citation><mixed-citation xml:lang="en">Головачева В.А., Головачева А.А., Парфенов В.А. Терапия при хронической мигрени: междисциплинарный подход. Клиническое наблюдение. Терапевтический архив. 2021;93(12):1528–1532. https://doi.org/10.26442/00403660.2021.12.201247. Golovacheva V.A., Golovacheva A.A., Parfenov V.A. Chronic migraine treatment: multidisciplinary approach. Case report. Terapevticheskii Arkhiv. 2021;93(12): 1528–1532. (In Russ.) https://doi.org/10.26442/00403660.2021.12.201247.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Olesen J., Bolay H., Charles A., Evers S., First M., Hershey A. et al. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.</mixed-citation><mixed-citation xml:lang="en">Olesen J., Bolay H., Charles A., Evers S., First M., Hershey A. et al. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Modarresi S., Lukacs M.J., Ghodrati M., Salim S., MacDermid J.C., Walton D.M. A Systematic Review and Synthesis of Psychometric Properties of the Numeric Pain Rating Scale and the Visual Analog Scale for Use in People With Neck Pain. Clin J Pain. 2021;38(2):132–148. https://doi.org/10.1097/AJP.0000000000000999.</mixed-citation><mixed-citation xml:lang="en">Modarresi S., Lukacs M.J., Ghodrati M., Salim S., MacDermid J.C., Walton D.M. A Systematic Review and Synthesis of Psychometric Properties of the Numeric Pain Rating Scale and the Visual Analog Scale for Use in People With Neck Pain. Clin J Pain. 2021;38(2):132–148. https://doi.org/10.1097/AJP.0000000000000999.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart W.F., Lipton R.B., Dowson A.J., Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl. 1):S20–28. https://doi.org/10.1212/wnl.56.suppl_1.s20.</mixed-citation><mixed-citation xml:lang="en">Stewart W.F., Lipton R.B., Dowson A.J., Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl. 1):S20–28. https://doi.org/10.1212/wnl.56.suppl_1.s20.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wei Y., Li H., Wang H., Zhang S., Sun Y. Psychological Status of Volunteers in a Phase I Clinical Trial Assessed by Symptom Checklist 90 (SCL-90) and Eysenck Personality Questionnaire (EPQ). Med Sci Monit. 2018;(24):4968–4973. https://doi.org/10.12659/MSM.909524.</mixed-citation><mixed-citation xml:lang="en">Wei Y., Li H., Wang H., Zhang S., Sun Y. Psychological Status of Volunteers in a Phase I Clinical Trial Assessed by Symptom Checklist 90 (SCL-90) and Eysenck Personality Questionnaire (EPQ). Med Sci Monit. 2018;(24):4968–4973. https://doi.org/10.12659/MSM.909524.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bados A., Gómez-Benito J., Balaguer G. The state-trait anxiety inventory, trait version: does it really measure anxiety? J Pers Assess. 2010;92(6):560–567. https://doi.org/10.1080/00223891.2010.513295.</mixed-citation><mixed-citation xml:lang="en">Bados A., Gómez-Benito J., Balaguer G. The state-trait anxiety inventory, trait version: does it really measure anxiety? J Pers Assess. 2010;92(6):560–567. https://doi.org/10.1080/00223891.2010.513295.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Henry S.K., Grant M.M., Cropsey K.L. Determining the optimal clinical cutoff on the CES-D for depression in a community corrections sample. J Affect Disord. 2018;(234):270–275. https://doi.org/10.1016/j.jad.2018.02.071.</mixed-citation><mixed-citation xml:lang="en">Henry S.K., Grant M.M., Cropsey K.L. Determining the optimal clinical cutoff on the CES-D for depression in a community corrections sample. J Affect Disord. 2018;(234):270–275. https://doi.org/10.1016/j.jad.2018.02.071.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Silberstein S.D., Stauffer V.L., Day K.A., Lipsius S., Wilson M.C. Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 &amp; EVOLVE-2). J Headache Pain. 2019;20(1):75. https://doi.org/10.1186/s10194-019-1024-x.</mixed-citation><mixed-citation xml:lang="en">Silberstein S.D., Stauffer V.L., Day K.A., Lipsius S., Wilson M.C. Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 &amp; EVOLVE-2). J Headache Pain. 2019;20(1):75. https://doi.org/10.1186/s10194-019-1024-x.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Katsarava Z., Buse D.C., Manack A.N., Lipton R.B. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92. https://doi.org/10.1007/s11916-011-0233-z.</mixed-citation><mixed-citation xml:lang="en">Katsarava Z., Buse D.C., Manack A.N., Lipton R.B. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92. https://doi.org/10.1007/s11916-011-0233-z.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Burch R.C., Buse D.C., Lipton R.B. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631–649. https://doi.org/10.1016/j.ncl.2019.06.001.</mixed-citation><mixed-citation xml:lang="en">Burch R.C., Buse D.C., Lipton R.B. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631–649. https://doi.org/10.1016/j.ncl.2019.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Buse D.C., Reed M.L., Fanning K.M., Bostic R., Dodick D.W., Schwedt T.J. et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. https://doi.org/10.1186/s10194-020-1084-y.</mixed-citation><mixed-citation xml:lang="en">Buse D.C., Reed M.L., Fanning K.M., Bostic R., Dodick D.W., Schwedt T.J. et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. https://doi.org/10.1186/s10194-020-1084-y.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Peres M.F.P., Mercante J.P.P., Tobo P.R., Kamei H., Bigal M.E. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain. 2017;18(1):37. https://doi.org/10.1186/s10194-017-0742-1.</mixed-citation><mixed-citation xml:lang="en">Peres M.F.P., Mercante J.P.P., Tobo P.R., Kamei H., Bigal M.E. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain. 2017;18(1):37. https://doi.org/10.1186/s10194-017-0742-1.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Davis R.E., Smitherman T.A., Baskin S.M. Personality traits, personality disorders, and migraine: a review. Neurol Sci. 2013;34(1):S7–10. https://doi.org/10.1007/s10072-013-1379-8.</mixed-citation><mixed-citation xml:lang="en">Davis R.E., Smitherman T.A., Baskin S.M. Personality traits, personality disorders, and migraine: a review. Neurol Sci. 2013;34(1):S7–10. https://doi.org/10.1007/s10072-013-1379-8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mongini F., Fassino S., Rota E., Deregibus A., Levi M., Monticone D., Abbate-Daga G. The temperament and character inventory in women with migraine. J Headache Pain. 2005;6(4):247–249. https://doi.org/10.1007/s10194-005-0198-6.</mixed-citation><mixed-citation xml:lang="en">Mongini F., Fassino S., Rota E., Deregibus A., Levi M., Monticone D., Abbate-Daga G. The temperament and character inventory in women with migraine. J Headache Pain. 2005;6(4):247–249. https://doi.org/10.1007/s10194-005-0198-6.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hamedi V., Ameri V., Azamameri A. Comparison of Anxiety, Depression, Stress and Anger in Migraine, Diabetic and Cardiac Patients and Healthy People. Procedia – Social and Behavioral Sciences. 2013;(84):1885–1888. https://doi.org/10.1016/j.sbspro.2013.07.053.</mixed-citation><mixed-citation xml:lang="en">Hamedi V., Ameri V., Azamameri A. Comparison of Anxiety, Depression, Stress and Anger in Migraine, Diabetic and Cardiac Patients and Healthy People. Procedia – Social and Behavioral Sciences. 2013;(84):1885–1888. https://doi.org/10.1016/j.sbspro.2013.07.053.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Huber D., Henrich G. Personality traits and stress sensitivity in migraine patients. Behav Med. 2003;29(1):4–13. https://doi.org/10.1080/08964280309596169.</mixed-citation><mixed-citation xml:lang="en">Huber D., Henrich G. Personality traits and stress sensitivity in migraine patients. Behav Med. 2003;29(1):4–13. https://doi.org/10.1080/08964280309596169.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hedborg K., Anderberg U.M., Muhr C. Stress in migraine: personalitydependent vulnerability, life events, and gender are of significance. Ups J Med Sci. 2011;116(3):187–199. https://doi.org/10.3109/03009734.2011.573883.</mixed-citation><mixed-citation xml:lang="en">Hedborg K., Anderberg U.M., Muhr C. Stress in migraine: personalitydependent vulnerability, life events, and gender are of significance. Ups J Med Sci. 2011;116(3):187–199. https://doi.org/10.3109/03009734.2011.573883.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Garramone F., Baiano C., Russo A., D’Iorio A., Tedeschi G., Trojano L., Santangelo G. Personality profile and depression in migraine: a meta-analysis. Neurol Sci. 2020;41(3):543–554. https://doi.org/10.1007/s10072-019-04174-x.</mixed-citation><mixed-citation xml:lang="en">Garramone F., Baiano C., Russo A., D’Iorio A., Tedeschi G., Trojano L., Santangelo G. Personality profile and depression in migraine: a meta-analysis. Neurol Sci. 2020;41(3):543–554. https://doi.org/10.1007/s10072-019-04174-x.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Schäfer M.L. Typus melancholicus as a personality characteristic of migraine patients. Eur Arch Psychiatry Clin Neurosci. 1994;243(6):328–339. https://doi.org/10.1007/BF02195727.</mixed-citation><mixed-citation xml:lang="en">Schäfer M.L. Typus melancholicus as a personality characteristic of migraine patients. Eur Arch Psychiatry Clin Neurosci. 1994;243(6):328–339. https://doi.org/10.1007/BF02195727.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Caspar F. Studying Effects and Process in Psychotherapy for Personality Disorders. Psychopathology. 2018;51(2):141–148. https://doi.org/10.1159/000487895.</mixed-citation><mixed-citation xml:lang="en">Caspar F. Studying Effects and Process in Psychotherapy for Personality Disorders. Psychopathology. 2018;51(2):141–148. https://doi.org/10.1159/000487895.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Paris J., Black D.W. Psychotherapy for personality disorders is underfunded. Ann Clin Psychiatry. 2021;33(4):217–218. https://doi.org/10.12788/acp.0043.</mixed-citation><mixed-citation xml:lang="en">Paris J., Black D.W. Psychotherapy for personality disorders is underfunded. Ann Clin Psychiatry. 2021;33(4):217–218. https://doi.org/10.12788/acp.0043.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Green M.W., Muskin P.R. The neuropsychiatry of headache. UK: Cambridge University Press, 2013; 181 p. https://doi.org/10.1017/CBO9781139206952.013.</mixed-citation><mixed-citation xml:lang="en">Green M.W., Muskin P.R. The neuropsychiatry of headache. UK: Cambridge University Press, 2013; 181 p. https://doi.org/10.1017/CBO9781139206952.013.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Rothrock J., Lopez I., Zweilfer R., Andress-Rothrock D., Drinkard R., Walters N. Borderline personality disorder and migraine. Headache. 2007;47(1):22–26. https://doi.org/10.1111/j.1526-4610.2007.00649.x.</mixed-citation><mixed-citation xml:lang="en">Rothrock J., Lopez I., Zweilfer R., Andress-Rothrock D., Drinkard R., Walters N. Borderline personality disorder and migraine. Headache. 2007;47(1):22–26. https://doi.org/10.1111/j.1526-4610.2007.00649.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
